From the Institute for Basic Science media release: The burgeoning field of optogenetics has seen another breakthrough with the creation of a new plant-human hybrid protein molecule called OptoSTIM1. In South Korea, a research team led…
From the Elsevier media release: The latest issue of Biological Psychiatry presents the results of three studies implicating metabotropic glutamate receptor 2 (mGluR2) as a new molecular target for the treatment of addiction. Group II metabotropic…
From the University of Arkansas at Little Rock media release: A project at the University of Arkansas at Little Rock that could help millions of visually impaired people will move forward thanks to funding from the…
From the University of Florida media release: Stroke victims who use Medicaid or are uninsured were more likely to die, stay hospitalized longer and have worse medical outcomes than patients with private insurance, a study by…
From the Canadian Science Publishing (NRC Research Press) media release: New research shows that teaching young adolescents practical cooking skills leads to positive changes for the entire family. In an article published in Applied Physiology,…
From the Cornell University media release: Victory was sweet for the U.S. Women’s World Cup team 5-2 victory this weekend — but it’s a safe bet that the vanquished team from Japan was reaching for…
From the Brigham Young University media release: A group of preschoolers were given one shot to beat the world’s fastest builder of block towers. Unbeknownst to the children, it had already been decided who would…
From the University of California – Los Angeles media release: A new study by UCLA scientists adds to the understanding of the genetic architecture of schizophrenia. Past research has shown the impact of commonly occurring…
From the University of Kansas media release: Compulsory schooling laws instituted in the late 1800s and early 1900s caused more people in Northern states to marry people at their same education level and race, possibly contributing…
From the Institute for Quality and Efficiency in Health Care media release: Safinamide (trade name: Xadago) has been available since February 2015 as add-on therapy for the treatment of mid- to late-stage Parkinson disease in adults.…